DEFA14A: Pyxis Oncology Sets Date for Annual Stockholders Meeting

Pyxis Oncology will hold its annual stockholders meeting on June 11, 2024, to elect directors and ratify the appointment of Ernst & Young LLP as its independent accounting firm.

Summary

• Pyxis Oncology, Inc. will hold its annual meeting of stockholders on June 11, 2024, at 10:00 AM Eastern Time.
• The meeting will be held live via the internet at www.proxydocs.com/PYXS.
• Stockholders of record as of April 18, 2024, are eligible to vote.
• The agenda includes the election of one Class I director (Santhosh Palani) and three Class III directors (John Flavin, Lara Sullivan, and Jakob Dupont).
• The agenda also includes the ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024.
• Stockholders can access proxy materials and vote online at www.proxydocs.com/PYXS using a 12-digit control number.
• Paper copies of proxy materials can be requested by calling 1-866-648-8133 or emailing paper@investorelections.com by May 31, 2024, to receive them in time for the meeting.

Sentiment

Score: 7

Explanation: The document is a standard announcement of an annual meeting, which is a neutral event. The board's recommendation to vote 'FOR' proposals 1 and 2 adds a slightly positive tone.

Positives

• The meeting provides an opportunity for stockholders to participate in key decisions regarding the company's governance.
• The online format allows for broader accessibility to the meeting.

Future Outlook

The document outlines the agenda for the upcoming annual meeting, focusing on electing directors and ratifying the appointment of the independent accounting firm.

Industry Context

This is a standard annual meeting announcement, a routine part of corporate governance for publicly traded companies.

Stakeholder Impact

• Shareholders have the opportunity to vote on key company matters.
• The outcome of the votes will impact the composition of the board of directors and the selection of the independent accounting firm.

Next Steps

• Stockholders should review the proxy materials and vote on the proposals.
• Attend the annual meeting on June 11, 2024, if desired.

Key Dates

Keywords

Pyxis Oncology, annual meeting, stockholders, proxy statement, directors, Ernst & Young, voting, governance